期刊文献+

云克治疗67例骨转移癌的临床观察 被引量:2

Clinical observation on ^(99)Tc-MDP in 67 patients with bone metastases
下载PDF
导出
摘要 观察云克 ( 99Tc MDP)治疗恶性肿瘤骨转移的临床疗效及不良反应。取云克冻干品 2 0 0mg ,用 2 5 0~ 5 0 0mL生理盐水溶解 ,静脉滴入 3h ,连续 5d为 1个疗程 ;隔 1周或隔 2周重复治疗。 2个疗程以上者统计资料分析。结果云克治疗骨转移癌疼痛的总有效率为 82 % ( 5 5 /67) ;改善活动障碍的有效率为 72 % ( 18/2 5 ) ;止痛维持时间平均1个月 ;无明显不良反应。初步研究结果提示 ,云克是一种治疗恶性肿瘤骨转移的有效药物 ,能有效缓解骨痛、改善活动功能障碍、降低血钙、提高患者生活质量 ; The objective of this work was to study the clinical effect of 99Tc-MDP on bone metastasis. 99Tc-MDP 200 mg was dissolved in 0.9% NS 250-500 mL and venous drip for 3 hours in 67 patients with bone metastasis for continuous 5 days, then the drip treatment was repeated after one or two weeks for 5 days.The clinical efficacy was observed on pain degree, active efficacy and some other test indices.The results showed the total remission rate of pain was 82%(55/67),and 72%(18/25) of action was improved and average sustainable time in pain remission was about one month. The initial result indicated that 99Tc-MDP could remit the pain in bone metastasis event and improve the physical action as well as the quality of life. Chin J Cancer Prev Treat,2004,11(10):1097-1098
出处 《肿瘤防治杂志》 2004年第10期1097-1098,共2页 China Journal of Cancer Prevention and Treatment
关键词 骨肿瘤/继发性 骨肿瘤/药物疗法 ^99m锝美罗酸盐/投药和剂量 bone neoplasm/secondary bone neoplasm/drug therapy technetium Tc 99m medronate/administration & dosage
  • 相关文献

参考文献7

二级参考文献14

共引文献83

同被引文献22

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部